Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine infiltration for pain control after perianal surgery
IRCT20260528069554N1Phase 4Recruiting
- Sponsor
- Fatima Memorial Hospital
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of ropivacaine in anal fistula, chronic anal fissure (CAF) and hemorrhoid (2 arms), sponsored by Fatima Memorial Hospital. Primary endpoints: Post-operative pain, Post-operative analgesic requirements and 1 more. Started Oct 2026; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
anal fistulachronic anal fissure (CAF)hemorrhoid
Beyond the preview
Go deeper on IRCT20260528069554N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260528069554N1.